Nevaris Pharma develops and commercialises niche, complex generic medicines the formulations where difficulty in manufacturing and evidence generation is the barrier to entry, and where we specialise.
Nevaris Pharma is a speciality pharmaceutical company built around a single premise: the harder a medicine is to formulate, evidence, and register, the fewer companies can deliver it.
Our focus sits in complex generic formulations combination products, narrow therapeutic index actives, and modified release technologies.
More About UsFixed dose, multi component formulations requiring aligned pharmacokinetics.
Formulation and bioequivalence work where small variance carries clinical consequence.
Release profile engineering including soft gel and micronised actives.
CTD format submissions built on public domain clinical evidence and expert synthesis.
Immediate & modified release
Hard shell, dual compartment
Micronised active suspension
Sterile vial & prefilled formats
Topical, dermal application
Topical, sustained delivery
We collaborate with CDMOs, licensing partners, and distributors on the development and commercialisation of differentiated, value added medicines.